Your browser doesn't support javascript.
loading
A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase.
Wu, X L; Zhao, X Q; Zhang, B X; Xuan, F; Guo, H M; Ma, F T.
Affiliation
  • Wu XL; Department of Pediatric Hematology-Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhao XQ; Department of Pediatric Hematology-Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhang BX; Department of Pediatric Hematology-Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Xuan F; Department of Pediatric Hematology-Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Guo HM; Department of Pediatric Hematology-Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Ma FT; Department of Pediatric Hematology-Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Braz J Med Biol Res ; 50(4): e5727, 2017 Mar 23.
Article in En | MEDLINE | ID: mdl-28355352
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chediak-Higashi Syndrome / Frameshift Mutation Type of study: Diagnostic_studies Limits: Humans / Infant / Male Language: En Journal: Braz J Med Biol Res Year: 2017 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chediak-Higashi Syndrome / Frameshift Mutation Type of study: Diagnostic_studies Limits: Humans / Infant / Male Language: En Journal: Braz J Med Biol Res Year: 2017 Document type: Article